USPTO 2015–2025 USPTO PatentsView US Corporation

Tempus LABS, Inc.

USPTO PatentsView assignee record - 63 granted patents across 20 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

33.7

Avg claims per patent

+6100%

5-year filing velocity

The verdict

Tempus holds 63 US patents across 20 technology areas, rank #5,478 of 50,000 tracked assignees.

#5,478
of 50,000 US assignees by volume: Top 4%
by Innovation Score (58.5/100): 33.7
avg claims per patent: +6100%
filing velocity, last 5 yrs

Portfolio overview

Tempus LABS, Inc. has been granted 63 US utility patents between 2019 and 2024, placing Tempus LABS, Inc. at rank #5,478 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 33.7 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, Tempus LABS, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Tempus sits between Skyhook Wireless, Inc. (63 patents, rank #5,474) and Unlikely Artificial Intelligence Limited (63 patents, rank #5,482) - the closest US assignees by grant volume. The composite Innovation Score of 58.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 62 grants, compared with 1 in the 2015–2019 window, a +6100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Tempus LABS, Inc.'s 33.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Tempus LABS, Inc. against peers pursuing similar technology classes.

Skyhook Wireless

63
Sumitomo Pharma

63
Suncor Energy

63
Taser Internation…

63
Therma-stor

63
Tyco UK

63
University Indust…

63
Unlikely Artifici…

63
Tempus LABS ◀

63

What this shows Tempus holds 63 patents at rank #5,478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tempus

By rank, the assignees closest to #5,478 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Tempus's primary technology class.

Tempus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Tempus LABS, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	1.6%
2020	2	3.2%
2021	18	28.6%
2022	18	28.6%
2023	21	33.3%
2024	3	4.8%

Which technologies does Tempus LABS, Inc. patent most?

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 38

G06F - ELECTRIC DIGITAL DATA PROCESSING 27

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 26

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 21

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 16

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 14

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 11

G06Q - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR 7

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 6

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 5

G10L - SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING 3

H04B - TRANSMISSION 3

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 2

C07K - PEPTIDES 2

Top 15 of 20 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#5,478

Across all tracked assignees

Innovation Score

58.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Tempus LABS, Inc. hold?

Tempus LABS, Inc. holds 63 US granted patents filed between 2019 and 2024, spanning 20 technology areas.

What is Tempus LABS, Inc.'s Innovation Score?

Tempus LABS, Inc. has an Innovation Score of 58.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Tempus LABS, Inc. focus on?

Tempus LABS, Inc.'s top technology area is G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA) with 38 patents. The company has filed patents in 20 CPC subclasses total.

Is Tempus LABS, Inc.'s patent filing rate increasing or decreasing?

Tempus LABS, Inc.'s recent filing velocity is +6100% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Tempus LABS, Inc.'s patents?

Tempus LABS, Inc.'s patents average 33.7 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Tempus LABS, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Tempus's 63 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Tempus ranks #5,478 of 50,000. Top 50 holders
Most of this portfolio concentrates in G16H - see who else leads that technology area. G16H leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.